RecruitingNot ApplicableNCT05562232

The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms

The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms - a Pilot Study Protocol

Sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Enrollment

45 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Mild Traumatic Brain Injury Concussion, Brain

Summary

The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.

Eligibility

Min Age: 20 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Creatine Monohydrate for people with concussion, brain and mild traumatic brain injury. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.